Comparison of referring and final pathology for patients with T-cell lymphoma in the National Comprehensive Cancer Network-Reference-Cited by-同舟云学术

Comparison of referring and final pathology for patients with T-cell lymphoma in the National Comprehensive Cancer Network

Published:2014-04-04 Issue:13 Volume:120 Page:1993-1999
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Herrera Alex F.¹,Crosby-Thompson Allison²,Friedberg Jonathan W.³,Abel Gregory A.¹,Czuczman Myron S.⁴,Gordon Leo I.⁵,Kaminski Mark S.⁶,Millenson Michael M.⁷,Nademanee Auayporn P.⁸,Niland Joyce C.⁸,Rodig Scott J.⁹,Rodriguez Maria A.¹⁰,Zelenetz Andrew D.¹¹,LaCasce Ann S.¹

Affiliation:

1. Department of Medical Oncology; Dana-Farber Cancer Institute; Boston Massachusetts

2. Division of Population Sciences; Dana-Farber Cancer Institute; Boston Massachusetts

3. Department of Hematology and Oncology, James P. Wilmot Cancer Center; University of Rochester; Rochester New York

4. Department of Hematology and Oncology; Roswell Park Cancer Institute; Buffalo New York

5. Deparment of Hematology-Oncology; Northwestern University; Chicago Illinois

6. Division of Hematology and Oncology; University of Michigan Comprehensive Cancer Center; Ann Arbor Michigan

7. Department of Medical Oncology; Fox Chase Cancer Center; Philadelphia Pennsylvania

8. Department of Hematology and Hematopoietic Cell Transplantation; City of Hope Cancer Center; Duarte California

9. Department of Pathology; Brigham and Women's Hospital; Boston Massachusetts

10. Department of Lymphoma/Myeloma, Division of Cancer Medicine; The University of Texas M. D. Anderson Cancer Center; Houston Texas

11. Lymphoma Service, Department of Medicine; Memorial Sloan-Kettering Cancer Center; New York New York

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.28676/fullpdf

Reference21 articles.

1. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes;Vose;J Clin Oncol.,2008

2. Long-term outcome of adults with systemic anaplastic large-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte trials;Sibon;J Clin Oncol.,2012

3. Prolonged survival of patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation: the GELTAMO experience;Rodriguez;Eur J Haematol.,2007

4. Frontline autologous stem cell transplantation in high-risk peripheral T-cell lymphoma: a prospective study from the Gel-Tamo Study Group;Rodriguez;Eur J Haematol.,2007

5. Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation;Schetelig;Haematologica.,2003

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integration of T‐cell clonality screening using TRBC‐1 in lymphoma suspect samples by flow cytometry;Cytometry Part B: Clinical Cytometry;2023-11-27

2. Influence of treatment intensity and medical comorbidities in older adults with peripheral T cell lymphoma;Leukemia & Lymphoma;2023-09-14

3. SOHO State of the Art Updates and Next Questions | Challenging Cases in Rare T-Cell Lymphomas;Clinical Lymphoma Myeloma and Leukemia;2023-09

4. Diagnostic significance of dysregulated miRNAs in T-cell malignancies and their metabolic roles;Frontiers in Oncology;2023-08-10

5. Clinical approaches for integrating machine learning for patients with lymphoma: Current strategies and future perspectives;British Journal of Haematology;2023-05-11